As part of our COVID-19 Impact Series, we have been exploring potential impacts to our nationwide network of health system specialty pharmacies. Read More >

White Papers

How Specialty Pharmacy Networks are Redefining the Role of IDNs for Drug Manufacturers

Group 8 Created with Sketch.

This white paper points out that while complex patients usually receive care in a health system context, health systems often do not have access to specialty drugs those patients need. A network like Excelera connects drug manufacturers with health systems.

  • Drug access is an issue for health system specialty pharmacies.
  • Networks such as Excelera offer a high-quality, patient-centered specialty pharmacy solution.
  • Robust, real-world data from Excelera Network members, aggregated into one data feed, is one advantage.
  • * Required fields
  • This field is for validation purposes and should be left unchanged.

LinkedIn icon